Abstract
Controlled Clinical Trials is an international journal covering the design, methods, and operational aspects of clinical trials. The readership is drawn from medicine, biostatistics, epidemiology, computer science, management science, behavioral science, pharmaceutical science, and bioethics.
References
- 1 Altman, Y. (1977). Elsevier Letter to Various People Regarding Possible Clinical Trials Journal, Personal Communication, October 28.
- 2 Aspirin Myocardial Infarction Study Research Group (1980). A randomized, controlled trial of aspirin in persons recovered from myocardial infarction, Journal of the American Medical Association 243, 661–669.
- 3 Aspirin Myocardial Infarction Study Research Group (1980). Aspirin Myocardial Infarction Study: Design, Methods, and Baseline Results, Publ. No. 80–2106, National Heart, Lung, and Blood Institute, Bethesda.
- 4 Coordinating Center Models Project Research Group (1979). Coordinating Center Models Project: a Study of Coordinating Centers in Multicenter Clinical Trials: I. Design and Methods (in two parts), Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland, March.
- 5 Coordinating Center Models Project Research Group (1979). Coordinating Center Models Project: a Study of Coordinating Centers in Multicenter Clinical Trials: XVI: CCMP Manuscripts Presented at the Annual Symposium on Coordinating Clinical Trials, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
- 6 Coronary Artery Surgery Study Research Group (1983). Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data, Circulation 68, 939–950.
- 7 Coronary Artery Surgery Study Research Group (1981). National Heart, Lung, and Blood Institute Coronary Artery Surgery Study: a multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography (edited by T. Killip, L.D. Fisher & M.B. Mock), Circulation 63, Supplement, I-1–I-81.
- 8
Coronary Drug Project Research Group
(1973).
The Coronary Drug Project: design, methods, and baseline results,
Circulation
47,
I-1–I-50.
10.1161/01.CIR.47.3S1.I-1 Google Scholar
- 9 Fisher, R. A. (1946). Statistical Methods for Research Workers, 10th Ed. Oliver & Boyd, Edinburgh.
- 10 Fredrickson, D. S. (1968). The field trial: some thoughts on the indispensable ordeal, Bulletin of the New York Academy of Medicine 44, 985–993.
- 11 Hill, A. B. (1962). Statistical Methods in Clinical and Preventive Medicine. Oxford University Press, New York.
- 12 Hypertension Detection and Follow-up Program Cooperative Group (1976). The Hypertension Detection and Follow-up Program, Preventive Medicine 5, 207–215.
- 13 Hypertension Detection and Follow-up Program Cooperative Group (1977). Blood pressure studies in 14 communities: a two-stage screen for hypertensives, Journal of the American Medical Association 237, 2385–2391.
- 14 Kolata, G. B. (1977). Clinical trials: methods and ethics are debated, Science 198, 1127–1131.
- 15 Lipid Research Clinics Program (1979). The Coronary Primary Prevention Trial: design and implementation, Journal of Chronic Diseases 32, 609–631.
- 16 Lipid Research Clinics Program (1984). The Lipid Research Clinics Coronary Primary Prevention Trial Results, I. Reduction in incidence of coronary heart disease, Journal of the American Medical Association 251, 351–364.
- 17 Medical Research Council (1931). Clinical trials of new remedies (annotations), Lancet 2, 304.
- 18 Meinert, C. L. (1977). Prospectus for a Journal on the Methodology of Controlled Clinical Trials, Personal Communication, October 26.
- 19 Meinert, C. L. (1980). Why another journal?, Controlled Clinical Trials 1, 1–2.
- 20
Meinert, C. L.
(1981).
The first year,
Controlled Clinical Trials
2,
1.
10.1016/0197-2456(81)90053-2 Google Scholar
- 21 Meinert, C. L. (1990). The Journal after 10 years, Controlled Clinical Trials 11, 1–3.
- 22
Meinert, C. L.
(1994).
Farewell swan song,
Controlled Clinical Trials
15,
235–237.
10.1016/0197-2456(94)90038-8 Google Scholar
- 23 Meinert, C. L. & Hawkins, B. S. (1979). Methodology: the case for improved communications, Clinical Pharmacology and Therapeutics 25, 754–757.
- 24 Multiple Risk Factor Intervention Trial Research Group (1977). Statistical design considerations in the NHLBI Multiple Risk Factor Intervention Trial (MRFIT), Journal of Chronic Diseases 30, 261–275.
- 25 Multiple Risk Factor Intervention Trial Research Group (1982). Multiple Risk Factor Intervention trial: risk factor changes and mortality results, Journal of the American Medical Association 248, 1465–1477.
- 26 Resource Committee of the Coordinating Center Models Project (1979). Minutes of the New Orleans Meeting, New Orleans, March.
- 27 Roth, H. P. (1979). Memo to Prospective Participants in the Scientific Sessions of the Society for Clinical Trials and Seventh Annual Symposium on Coordinating Clinical Trials, Personal Communication, October 26.
- 28 Roth, H. P. (1980). On the Society for Clinical Trials, Controlled Clinical Trials 1, 81–82.
- 29 Schimmel, J. (1978). Memo to Registrants—National Conference on Clinical Trials Methodology, regarding Need for Society, Journal, Annual Meeting.
- 30 Society for Clinical Trials (1980). Abstracts of the Combined Annual Scientific Sessions of the Society for Clinical Trials and the Seventh Annual Symposium for Coordinating Clinical Trials, Controlled Clinical Trials 1, 167–180.
- 31
Society for Clinical Trials
(1980).
Society for Clinical Trials, Inc.: bylaws,
Controlled Clinical Trials
1,
83–89.
10.1016/S0197-2456(80)80011-0 Google Scholar
- 32 Society for Clinical Trials (1981). Abstracts of the Combined Annual Scientific Sessions of the Society for Clinical Trials and the Eighth Annual Symposium for Coordinating Clinical Trials, Controlled Clinical Trials 2, 67–89.
- 33
Society for Clinical Trials
(1981).
Preliminary Program of the Combined Annual Scientific Sessions of the Society for Clinical Trials and the Eighth Annual Symposium for Coordinating Clinical Trials,
Controlled Clinical Trials
2,
59–65.
10.1016/0197-2456(81)90058-1 Google Scholar
- 34 University Group Diabetes Program Research Group (1970). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: I. Design, methods, and baseline characteristics, Diabetes 19, 747–783.
- 35 University Group Diabetes Program Research Group (1970). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: II. Mortality results, Diabetes 19, 785–830.
- 36 US Congress (1962). Public Law No. 87–781: Drug Amendments of 1962, 76 Stat. 780.
Citing Literature
